Gerrit A van Essen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gerrit A van Essen has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
E Forleo
Vigivirus, Sao Paulo, Brazil
2 shared publicationsA Palache
1 shared publicationA.M Palache
Solvay Pharmaceuticals BV, Weesp, The Netherlands
1 shared publication- Albert Jm van Wijck
Department of Anaesthesiology, University Medical Center Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands
1 shared publication - Annette Aa Bak
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, PO Box 85060, 3500 AB Utrecht, The Netherlands
1 shared publication C De Baat
1 shared publication
Latest Publications
- Open Access
- 14 June 2007
- Published by Springer Nature in BMC Public Health
- Vol. 7 (1) , 113
Variations in influenza vaccination coverage among the high-risk population in Sweden in 2003/4 and 2004/5: a population survey
In Sweden, the vaccination campaign is the individual responsibility of the counties, which results in different arrangements. The aim of this study was to find out whether influenza vaccination coverage rates (VCRs) had increased between 2003/4 and 2004/5 among population at high risk and to find out the influence of personal preferences, demographic characteristics and health care system characteristics on VCRs.
- 14 June 2007
- Published by Springer Nature in BMC Public Health
- Vol. 7 (1) , 113
Open AccessVariations in influenza vaccination coverage among the high-risk population in Sweden in 2003/4 and 2004/5: a population survey
In Sweden, the vaccination campaign is the individual responsibility of the counties, which results in different arrangements. The aim of this study was to find out whether influenza vaccination coverage rates (VCRs) had increased between 2003/4 and 2004/5 among population at high risk and to find out the influence of personal preferences, demographic characteristics and health care system characteristics on VCRs.
- 1 March 2006
- Vol. 113 (3) , 113-5
[Cheek swelling after surgical removal of third molar].
A 55-years-old man visited his family doctor because of a one-day existing, not painful, right-sided swelling of the cheek. It appeared to be a subcutaneous emphysema, caused at an attempt to remove mandibular third molar roots, using a water- and air-cooled air rotor. Rare potential seũelae resulting from subcutaneous emphysema are venous air embolism, airway obstruction because of neck swelling, pneumomediastinum, and mediastinitis. Using air-cooled instruments in surgical orofacial treatments should be avoided because of the possible atrogenic life-threatening complications.
- 1 March 2006
- Vol. 113 (3) , 113-5
[Cheek swelling after surgical removal of third molar].
A 55-years-old man visited his family doctor because of a one-day existing, not painful, right-sided swelling of the cheek. It appeared to be a subcutaneous emphysema, caused at an attempt to remove mandibular third molar roots, using a water- and air-cooled air rotor. Rare potential seũelae resulting from subcutaneous emphysema are venous air embolism, airway obstruction because of neck swelling, pneumomediastinum, and mediastinitis. Using air-cooled instruments in surgical orofacial treatments should be avoided because of the possible atrogenic life-threatening complications.
- 1 June 2004
- Published by Elsevier in International Congress Series
- Vol. 1263, 94-97
Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries
- 1 June 2004
- Published by Elsevier in International Congress Series
- Vol. 1263, 94-97
Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries
- Open Access
- 26 January 2004
- Published by Springer Nature in BMC Anesthesiology
- Vol. 4 (1) , 2
The PINE study: rationale and design of a randomised comparison of epidural injection of local anaesthetics and steroids versus care-as-usual to prevent postherpetic neuralgia in the elderly [ISRCTN32866390]
Postherpetic neuralgia (PHN) is by far the most common complication of herpes zoster (HZ) and one of the most intractable pain disorders. Since PHN is seen most often in the elderly, the number of patients with this disorder is expected to increase in our ageing society. PHN may last for months to years and has a high impact on the quality of life. The results of PHN treatment are rather disappointing. Epidural injection of local anaesthetics and steroids in the acute phase of HZ is a promising therapy for the prevention of PHN. Since randomised trials on the effectiveness of this intervention are lacking, the PINE (Prevention by epidural Injection of postherpetic Neuralgia in the Elderly) study was set up. The PINE study compares the effectiveness and cost-effectiveness of a single epidural injection of local anaesthetics and steroids during the acute phase of HZ with that of care-as-usual (i.e. antivirals and analgesics) in preventing PHN in elderly patients. The PINE study is an open, multicenter clinical trial in which 550 elderly (age ≥ 50 yr.) patients who consult their general practitioner in the acute phase of HZ (rash < 7 days) are randomised to one of the treatment groups. The primary clinical endpoint is the presence of HZ-related pain one month after the onset of the rash. Secondary endpoints include duration and severity of pain, re-interventions aiming to treat the existing pain, side effects, quality of life, and cost-effectiveness. The PINE study is aimed to quantify the (cost-) effectiveness of a single epidural injection during the acute phase of HZ on the prevention of PHN.
- 26 January 2004
- Published by Springer Nature in BMC Anesthesiology
- Vol. 4 (1) , 2
Open AccessThe PINE study: rationale and design of a randomised comparison of epidural injection of local anaesthetics and steroids versus care-as-usual to prevent postherpetic neuralgia in the elderly [ISRCTN32866390]
Postherpetic neuralgia (PHN) is by far the most common complication of herpes zoster (HZ) and one of the most intractable pain disorders. Since PHN is seen most often in the elderly, the number of patients with this disorder is expected to increase in our ageing society. PHN may last for months to years and has a high impact on the quality of life. The results of PHN treatment are rather disappointing. Epidural injection of local anaesthetics and steroids in the acute phase of HZ is a promising therapy for the prevention of PHN. Since randomised trials on the effectiveness of this intervention are lacking, the PINE (Prevention by epidural Injection of postherpetic Neuralgia in the Elderly) study was set up. The PINE study compares the effectiveness and cost-effectiveness of a single epidural injection of local anaesthetics and steroids during the acute phase of HZ with that of care-as-usual (i.e. antivirals and analgesics) in preventing PHN in elderly patients. The PINE study is an open, multicenter clinical trial in which 550 elderly (age ≥ 50 yr.) patients who consult their general practitioner in the acute phase of HZ (rash < 7 days) are randomised to one of the treatment groups. The primary clinical endpoint is the presence of HZ-related pain one month after the onset of the rash. Secondary endpoints include duration and severity of pain, re-interventions aiming to treat the existing pain, side effects, quality of life, and cost-effectiveness. The PINE study is aimed to quantify the (cost-) effectiveness of a single epidural injection during the acute phase of HZ on the prevention of PHN.